Isobaric Tags for Relative and Absolute Quantitation in Proteomic Analysis of Potential Biomarkers in Invasive Cancer, Ductal Carcinoma In Situ, and Mammary Fibroadenoma
Hao Wu,Xian-Yu Zhang,Ming Niu,Fei-Feng Li,Song Gao,Wei Wei,Si-Wei Li,Xing-Da Zhang,Shu-Lin Liu,Da Pang
DOI: https://doi.org/10.3389/fonc.2020.574552
IF: 4.7
2020-10-21
Frontiers in Oncology
Abstract:<span><strong>Objectives:</strong> Breast malignancy is a serious threat to women's health around the world. Following the rapid progress in the field of cancer diagnostics and identification of pathological markers, breast tumor treatment methods have been greatly improved. However, for invasive, ductal carcinomas and mammary fibroadenoma, there is an urgent demand for better breast tumor-linked biomarkers. The current study was designed to identify diagnostic and/or therapeutic protein biomarkers for breast tumors.<strong>Methods:</strong> A total of 140 individuals were included, comprising 35 healthy women, 35 invasive breast cancers (IBC), 35 breast ductal carcinomas <i>in situ</i> (DCIS), and 35 breast fibroadenoma patients. <i>Isobaric tags for relative and absolute quantitation (</i>iTRAQ) proteomic analysis was employed to characterize differentially expressed proteins for potential biomarkers in IBC, DCIS, and fibroadenomas by comparisons with their matched adjacent tissues and/or normal breast tissues. The public databases Metascape and String were used for bioinformatic analyses.<strong>Results:</strong> Using the proteomics approach, we identified differentially expressed proteins in tissues of different breast tumors compared to normal/adjacent breast tissues, including 100 in IBC, 52 in DCIS, and 44 in fibroadenoma. Among the 100 IBC differentially expressed proteins, 37 were found to be specific to this type of cancer only. Additionally, four proteins were specifically expressed in DCIS and four in fibroadenoma. Compared to corresponding adjacent tissues and normal breast tissues, 18 step-changing proteins were differentially expressed in IBC, 14 in DCIS, and 13 in fibroadenoma, respectively. Compared to DCIS and normal breast tissues, 65 proteins were differentially expressed in IBC with growing levels of malignancy.<strong>Conclusions:</strong> The identified potential protein biomarkers may be used as diagnostic and/or therapeutic targets in breast tumors.</span>
oncology